Clinical trials
Type 1 diabetes clinical trials
An autoimmune condition where the body makes little or no insulin. We’re tracking 862 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06993454Recruiting
Exercise and blood sugar in type 2 diabetes with fatty liver
This study looks at how a single session of exercise affects the body's natural sugar production in people with type 2 diabetes and fatty liver. It may help us find better ways to control blood sugar and treat fatty liver.
Orlando, FloridaAges 25–55 - NCT07431359Recruiting
Mediterranean diet study for type 2 diabetes patients
This trial looks at what people with type 2 diabetes know about diet and how often they eat a Mediterranean diet. It aims to understand if this way of eating can help with diabetes management.
Peschiera del Garda, VeronaAges 18–80 - NCT07098663RecruitingPhase 2
Study of MKP10241 for weight loss and diabetes control
This study tests an investigational drug called MKP10241 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects blood sugar, weight, and overall safety. It may be an option if you have obesity or type 2 diabetes managed by diet and/or metformin.
Bayswater, VictoriaAges 18–60 - NCT06989697RecruitingPhase 3
Cilostazol and ginkgo for memory in older adults with diabetes
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
Seongnam-siAges 60 years+ - NCT06923644Recruiting
Personalized nutrition plan to prevent metabolic disease
This study tests whether a personalized nutrition plan based on your unique metabolism can help prevent chronic metabolic diseases like type 2 diabetes. You will follow a tailored diet and have your health monitored over time.
MaastrichtAges 40–75 - NCT06549400Enrolling by invitationPhase 3
Study on long-term safety of mexiletine for myotonic dystrophy
This study tests if a daily capsule of mexiletine is safe and helpful over 26 weeks for people with myotonic dystrophy type 1 or 2. It's for people who finished a previous related study and want to continue treatment.
LeuvenAges 16 years+ - NCT06523400RecruitingPhase 3
Mexiletine for myotonic dystrophy types 1 and 2
This trial tests a once-daily drug called mexiletine PR to see if it can help reduce muscle stiffness (myotonia) in people with myotonic dystrophy type 1 or 2. It may be a good option if you have a confirmed genetic diagnosis and are at least 16 years old.
LeuvenAges 16 years+ - NCT06246799RecruitingPhase 3
Comparing two pill combinations for new diabetes
This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.
San Antonio, TexasAges 18–75 - NCT04791371Recruiting
Study how fitness and insulin resistance relate to diabetes
This study looks at how low physical activity, insulin resistance in small blood vessels, and cardiorespiratory fitness connect to diabetes and blood sugar control. You may be eligible if you are generally sedentary and fit within the weight range, and if you do not have certain heart, lung, nerve, or medication factors.
Aurora, ColoradoAges 30–55 - NCT07776509RecruitingPhase 3
Adding a new drug to current weight-loss therapy for adults with obesity or overweight
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
Escondido, CaliforniaAges 18 years+ - NCT06846138Enrolling by invitation
Herbal supplement to help metformin work better and cause fewer side effects
This study tests a special herbal blend added to metformin to see if it helps reduce stomach problems and improves blood sugar control in people with type 2 diabetes. Researchers want to understand how the herbs affect the bacteria in your gut.
RigaAges 25–80 - NCT07187479Recruiting
Testing a new insulin approach for kidney disease and diabetes
This study tests a new approach to help your body use insulin better, which may improve blood sugar control and slow down kidney disease. It is for people with advanced chronic kidney disease and type 2 diabetes who are not yet on dialysis.
Phoenix, ArizonaAges 18 years+ - NCT06954090Enrolling by invitationPhase 4
Urine test to guide early treatment in type 2 diabetes
This study looks at whether a urine test can help doctors choose the right medicines earlier to prevent kidney and heart problems in people with type 2 diabetes. You may join if you have type 2 diabetes but no severe heart failure.
Herlev, Hajdú-BiharAges 18 years+ - NCT07653477RecruitingPhase 3
New diabetes drug for type 2 diabetes not well controlled with metformin
This trial tests an investigational drug called UBT251 for people with type 2 diabetes whose blood sugar is not well controlled despite taking metformin, either alone or with another diabetes medicine. The goal is to see if it can lower blood sugar levels more than a placebo.
ShanghaiAges 18–75 - NCT05766735Recruiting
Lifestyle program to lower sugar spikes after meals
This trial studies whether a structured lifestyle program can reduce “sugar spikes” after meals in people with early type 2 diabetes. It may help by combining coaching, tracking, and meal/activity changes to improve blood sugar control.
Aurora, ColoradoAges 30–80 - NCT07659574RecruitingPhase 3
Study of UBT251 injection for type 2 diabetes not controlled by diet and exercise
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
Changsha, HunanAges 18–75 - NCT06958302Recruiting
Diabetes Nerve Damage and Muscle Mass in Type 2 Diabetes
This study examines how nerve damage from diabetes (diabetic neuropathy) relates to muscle loss in people with type 2 diabetes. It aims to help understand and possibly prevent muscle weakness.
Cairo, AbbassiaAges 45 years+ - NCT07658417Enrolling by invitation
Once-weekly insulin study for type 2 diabetes
This study tests whether switching from daily basal insulin to once-weekly insulin icodec improves blood sugar control, treatment satisfaction, and how well people stick with the new insulin. It may be a good option if you have type 2 diabetes and are already using a daily basal insulin.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07632404Enrolling by invitation
Switching to Once-Weekly Insulin: Blood Sugar Control and Satisfaction
This study looks at how well once-weekly insulin icodec controls blood sugar and improves quality of life for people with type 2 diabetes who currently take daily insulin injections. You'll switch from your daily insulin to a once-weekly injection and the study will track your blood sugar control, treatment satisfaction, and how well you stick with the new schedule.
Pescara, AbruzzoAges 18 years+ - NCT07278115Recruiting
Gastric bypass with or without nerve-cutting for diabetes
This study compares two types of surgery for people with type 2 diabetes who also have obesity: gastric bypass alone versus gastric bypass plus a procedure called truncal vagotomy (cutting a nerve to the stomach). It aims to see which approach leads to better diabetes remission.
Athens, AtticaAges 18–68 - NCT06649162Recruiting
Fatty liver risk in type 2 diabetes and new combo therapy
This study is looking at how often people with type 2 diabetes also have fatty liver disease, and whether a new combination medication (dapagliflozin and pioglitazone) can help manage both conditions.
Andong, Gyeongsangbuk-doAges 19 years+ - NCT07502508RecruitingPhase 2
Icovamenib for type 2 diabetes with Ozempic
This trial tests an investigational pill called icovamenib for people with type 2 diabetes who are already on Ozempic but still have high blood sugar. The goal is to see if adding icovamenib helps lower blood sugar more safely.
Birmingham, AlabamaAges 18–70 - NCT05770687Recruiting
Testing diabetes heart medicine soon after a heart attack
This study looks at how starting an SGLT2 inhibitor (a diabetes medicine) around the time of a heart attack affects heart outcomes and heart muscle changes over time. It may help you and your care team understand whether this timing is beneficial after a PCI procedure.
SeoulAges 19 years+ - NCT07083154RecruitingPhase 3
Mazdutide for type 2 diabetes with early memory problems
This study tests a new medication, Mazdutide, to see if it can slow or improve memory and thinking problems in people with type 2 diabetes and early-stage cognitive impairment. It may help by targeting blood sugar control and possibly reducing the impact of diabetes on brain function.
Changsha, HunanAges 50–75
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes?
- Yes. Clin2 currently lists 862 recruiting type 1 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.